The availability of multiple disease-modifying medications with regulatory approval to treat
multiple sclerosis illustrates the substantial progress made in therapy of the disease …

Neurodegenerative disorders are a variety of diseases including Alzheimer's (AD),
Parkinson's (PD), and Huntington's diseases (HD), multiple sclerosis (MS) and amyotrophic …

Bone marrow stromal stem cells (BMSCs) are adult multipotent cells, which have the
potential to differentiate into cell types of mesodermal origin, namely osteocytes, adipocytes …

Mesenchymal stem cells (MSCs) are non-hematopoietic, multipotent progenitor cells which
can be isolated from various human adult tissues. In recent years, MSCs have been shown …

Prolonged life expectancy, life style and environmental changes have caused a changing
disease pattern in developed countries towards an increase of degenerative and …

Background: Mesenchymal stem cells (MSCs) exhibit immunomodulatory, tissue-protective,
and repair-promoting properties in vitro and in animals. Clinical trials in several human …

Mesenchymal stem cells (MSCs) are pluripotent non-hematopoietic precursor cells that can
be isolated from bone marrow and numerous other tissues, culture-expanded to purity, and …

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system.
Umbilical cord derived mesenchymal stem cells are immunosuppressive. We transplanted …

Background: Mesenchymal stem cells can differentiate into endothelial cells and participate
in angiogenesis in adults. In experimental models of acute myocardial infarction …

MSCs, otherwise known as multipotent mesenchymal stromal cells, are being examined for
the treatment of autoimmune disease (AD) on the basis of their in vitro antiproliferative …